Hjem › Prostatakreft › Arizona › Tucson
Kliniske studier for Prostatakreft i Tucson, AZ
11 studier for Prostatakreft søker deltakere på steder i og rundt Tucson (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RekruttererFase 3
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RekruttererFase 2
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekruttererFase 3
- The University of Arizona Cancer Center - North Campus ( Site 0073), Tucson
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RekruttererFase 3
- University of Arizona Cancer Center, Tucson
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RekruttererFase 2
- The University of Arizona Cancer Center - North Campus, Tucson
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Arizona Cancer Center at University of Arizona, Tucson
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
RekruttererFase 1
- Arizona Urology Specialists, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- The University of Arizona Cancer Center, Tucson
4-aminopyridine Treatment for Nerve Injury
RekruttererFase 2/3
- University of Arizona, Tucson
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site 111, Tucson
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekruttererFase 3
- University of Arizona Cancer Center-Orange Grove Campus, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Prostatakreft-studier i andre byer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andre studier i Tucson
- Brystkreft20 studier
- Ikke-småcellet lungekreft17 studier
- Fedme17 studier
- Overvekt15 studier
- Metastatisk kreft14 studier
- Kreft (alle typer)12 studier
- Kardiovaskulær sykdom12 studier
- Kolorektal kreft11 studier
- Steatotisk leversykdom10 studier
- Hjertesvikt10 studier
- Høyt blodtrykk10 studier
- Type 2-diabetes10 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.